OpenFieldIU Medicine · Indianapolis, Indiana, United States
Indiana University School of Medicine is the largest allopathic medical school in the United States, anchored at the academic medical center in Indianapolis with nine regional campuses across Indiana. Conducting over $500 million in annual biomedical research, IU School of Medicine is a global leader in Alzheimer's disease genomics, pediatric oncology at Riley Hospital for Children, and organ transplantation.
Indianapolis · Nation's Largest Medical School, Precision Oncology & Neurosciences. Indiana University School of Medicine is the largest allopathic medical school in the United States, anchored at the academic medical center in Indianapolis with nine regional campuses across Indiana. Conducting over $500 million in annual biomedical research, IU School of Medicine is a global leader in Alzheimer's disease genomics, pediatric oncology at Riley Hospital for Children, and organ transplantation.
Completed bachelor's degree from an accredited institution with pre-medical prerequisites (biology, general/organic chemistry, biochemistry, physics). Competitive MCAT score and AMCAS application required. Demonstrated English proficiency required for international scholars (TOEFL iBT 100+ or IELTS 7.5+ for graduate biomedical sciences). AMCAS primary application deadline November 15, 2026; Secondary application deadline December 15, 2026; PhD graduate biomedical priority December 1, 2026.
NIH-funded MSTP program training physician-scientists in clinical medicine and fundamental biomedical research, including neurogenomics, cellular immunology, and cancer therapeutics.
Elite doctoral program investigating Alzheimer's pathology, neurodegenerative neuroinflammation, neural circuit optics, and addiction neurobiology.
Comprehensive four-year allopathic medical curriculum integrating early clinical immersion, organ-system pathophysiology, and longitudinal patient care across Indiana hospital systems.
Doctoral research examining cardiovascular molecular mechanics, diabetes renal physiology, microvascular transport, and metabolic signaling pathways.
Intensive two-year post-baccalaureate academic enhancer curriculum delivering medical-level histology, human biochemistry, anatomy, and MCAT coaching.
NIH NCI-designated Comprehensive Cancer Center fellowship in CAR-T cellular engineering, solid tumor microenvironment remodeling, and Phase I clinical trial biomarker assays.
Dean of the School of Medicine and Vice President for University Clinical Affairs
Office of the Dean and Department of Pathology
Dr. Jay L. Hess is a physician-scientist and hematopathologist leading IU School of Medicine, researching epigenetics in leukemia, MLL gene rearrangements, and ...
View researcher profile ↗Executive Director of the Stark Neurosciences Research Institute
Department of Medical and Molecular Genetics
Dr. Bruce Lamb is a world-renowned Alzheimer's disease researcher studying microglial biology, neuroinflammation, TREM2 signaling pathways, and transgenic mouse...
View researcher profile ↗Executive Associate Dean for Research Affairs and Chair of Medical Genetics
Department of Medical and Molecular Genetics
Dr. Tatiana Foroud directs the National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), investigating the genetic architecture of ...
View researcher profile ↗OpenField is an independent research platform not officially affiliated with Indiana University School of Medicine. Information reflects public documentation reviewed on 2026-10-16. Students must verify application deadlines, fee structures, and prerequisite details directly with official university admissions departments before applying.
Updated 2026-10-16 · Editorial policy · Submit corrections